• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nrf2: not "lost in translation".

作者信息

Hawley Robert G, Riz Irene

机构信息

Department of Anatomy and Regenerative Biology, George Washington University, Washington, DC 20052, USA.

出版信息

Aging (Albany NY). 2016 Dec 28;8(12):3153-3154. doi: 10.18632/aging.101152.

DOI:10.18632/aging.101152
PMID:28039442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5270657/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1587/5270657/8640973ae370/aging-08-3153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1587/5270657/8640973ae370/aging-08-3153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1587/5270657/8640973ae370/aging-08-3153-g001.jpg

相似文献

1
Nrf2: not "lost in translation".
Aging (Albany NY). 2016 Dec 28;8(12):3153-3154. doi: 10.18632/aging.101152.
2
Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.非经典SQSTM1/p62-Nrf2信号通路激活通过氧化还原、代谢和翻译重编程介导多发性骨髓瘤细胞对蛋白酶体抑制剂的耐药性。
Oncotarget. 2016 Oct 11;7(41):66360-66385. doi: 10.18632/oncotarget.11960.
3
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.NRF2 是多发性骨髓瘤骨髓介导的药物耐药性中的一个参与者。
Int J Mol Sci. 2018 Nov 7;19(11):3503. doi: 10.3390/ijms19113503.
4
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.通过Nrf2-AKR1C1通路的子宫内膜癌前病变/癌症中孕激素抵抗的机制
Oncotarget. 2016 Mar 1;7(9):10363-72. doi: 10.18632/oncotarget.7004.
5
p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ.p38丝裂原活化蛋白激酶依赖性Nrf2诱导增强胶质瘤细胞对替莫唑胺的抗性。
Med Oncol. 2015 Mar;32(3):69. doi: 10.1007/s12032-015-0517-y. Epub 2015 Feb 19.
6
Translational control of nrf2 protein in activation of antioxidant response by oxidants.氧化剂激活抗氧化反应过程中Nrf2蛋白的翻译调控
Mol Pharmacol. 2007 Oct;72(4):1074-81. doi: 10.1124/mol.107.035360. Epub 2007 Jul 25.
7
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer.NRF2通过调节胰腺癌中的mRNA翻译促进肿瘤维持。
Cell. 2016 Aug 11;166(4):963-976. doi: 10.1016/j.cell.2016.06.056. Epub 2016 Jul 28.
8
Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.耐药性与 MCF-7/DOX 细胞中 Nrf2 的激活有关，而黄苓素通过下调 Nrf2 介导的细胞防御反应来逆转这种情况。
Mol Carcinog. 2013 Oct;52(10):824-34. doi: 10.1002/mc.21921. Epub 2012 May 16.
9
Nrf2 inhibition sensitizes cholangiocarcinoma cells to cytotoxic and antiproliferative activities of chemotherapeutic agents.Nrf2抑制使胆管癌细胞对化疗药物的细胞毒性和抗增殖活性敏感。
Tumour Biol. 2016 Aug;37(8):11495-507. doi: 10.1007/s13277-016-5015-0. Epub 2016 Mar 25.
10
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.Nrf2转录因子有助于膀胱癌对顺铂产生耐药性。
Urol Oncol. 2014 Aug;32(6):806-14. doi: 10.1016/j.urolonc.2014.02.006. Epub 2014 May 16.

引用本文的文献

1
Single-cell RNA-sequencing of herpes simplex virus 1-infected cells connects NRF2 activation to an antiviral program.单细胞 RNA 测序分析单纯疱疹病毒 1 感染细胞，将 NRF2 激活与抗病毒程序联系起来。
Nat Commun. 2019 Oct 25;10(1):4878. doi: 10.1038/s41467-019-12894-z.
2
Increased expression of the tight junction protein TJP1/ZO-1 is associated with upregulation of TAZ-TEAD activity and an adult tissue stem cell signature in carfilzomib-resistant multiple myeloma cells and high-risk multiple myeloma patients.紧密连接蛋白TJP1/ZO-1的表达增加与卡非佐米耐药的多发性骨髓瘤细胞及高危多发性骨髓瘤患者中TAZ-TEAD活性上调和成体组织干细胞特征相关。
Oncoscience. 2017 Aug 1;4(7-8):79-94. doi: 10.18632/oncoscience.356. eCollection 2017 Jul.

本文引用的文献

1
Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.非经典SQSTM1/p62-Nrf2信号通路激活通过氧化还原、代谢和翻译重编程介导多发性骨髓瘤细胞对蛋白酶体抑制剂的耐药性。
Oncotarget. 2016 Oct 11;7(41):66360-66385. doi: 10.18632/oncotarget.11960.
2
Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.老年多发性骨髓瘤的管理：老年评估取得进展
J Geriatr Oncol. 2017 Jan;8(1):1-7. doi: 10.1016/j.jgo.2016.04.001. Epub 2016 Apr 23.
3
Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived Models.
Nrf2信号通路与延缓衰老表型：来自长寿模型的证据。
Oxid Med Cell Longev. 2015;2015:732596. doi: 10.1155/2015/732596. Epub 2015 Oct 25.
4
KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.KLF4-SQSTM1/p62相关的促生存自噬在多发性骨髓瘤模型中导致卡非佐米耐药。
Oncotarget. 2015 Jun 20;6(17):14814-31. doi: 10.18632/oncotarget.4530.
5
Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1.通过多能干细胞荧光染料 CDy1 鉴定 ABCB1（P-糖蛋白）阳性的卡非佐米耐药骨髓瘤亚群。
Am J Hematol. 2013 Apr;88(4):265-72. doi: 10.1002/ajh.23387. Epub 2013 Mar 8.
6
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.一项单药卡非佐米（PX-171-003-A1）治疗复发/难治性多发性骨髓瘤患者的 II 期研究。
Blood. 2012 Oct 4;120(14):2817-25. doi: 10.1182/blood-2012-05-425934. Epub 2012 Jul 25.
7
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.来那度胺和硼替佐米治疗后复发的多发性骨髓瘤的进展和生存风险：一项多中心国际骨髓瘤工作组研究。
Leukemia. 2012 Jan;26(1):149-57. doi: 10.1038/leu.2011.196. Epub 2011 Jul 29.